Expression of human telomerase reverse transcriptase in regenerative and precancerous lesions of cirrhotic livers

Wiley - Tập 22 Số 1 - Trang 57-69 - 2002
Vassiliki Kotoula1, Prodromos Hytiroglou2, Athina Pyrpasopoulou2, Romil Saxena3, Swan N. Thung3, Constantine S. Papadimitriou2
1Department of Pathology, Aristotle University Medical School, Thessaloniki, Greece
2Department of Pathology, Aristotle University Medical School, Thessaloniki, Greece, and
3The Lillian and Henry M. Stratton-Hans Popper Department of Pathology, Mount Sinai School of Medicine, New York, NY, USA

Tóm tắt

Abstract: Background/Aims: The catalytic subunit of human telomerase (hTERT) is known to be expressed in a variety of malignant tumours, including hepatocellular carcinoma (HCC). We studied hTERT expression in regenerative and precancerous lesions arising in cirrhosis. Methods/Results: As shown by in situ hybridisation, hTERT mRNA was absent in normal liver, but present in varying numbers of hepatocytes and HCC cells of diseased livers, as well as in biliary epithelial cells, lymphocytes, sinusoidal‐lining cells and tumour endothelial cells. RT‐PCR for two hTERT transcript regions demonstrated hTERT expression in 11 out of 15 cirrhotic liver samples, in 20 out of 21 large regenerative nodules/low‐grade dysplastic nodules, in 5 out of 5 high‐grade dysplastic nodules, and in 4 out of 4 HCCs. The beta‐splice variant was identified in all hTERT‐positive cases, while the corresponding full‐length transcript was found only in 13 out of 29 positive large nodular lesions and in 4 out of 11 positive cirrhotic samples. The full‐length transcript was always found in the presence of the beta‐splice variant, usually in low relative levels, and tended to correlate with telomerase activity in the samples, while the beta‐splice variant did not. Conclusions: This study shows that hTERT re‐expression takes place both in hepatic regeneration occurring in cirrhosis and in the early steps of hepatocarcinogenesis, and involves mainly the beta‐splice variant of this molecule. Additional regulatory mechanisms may be required for the expression of the full‐length hTERT transcript.

Từ khóa


Tài liệu tham khảo

10.1038/337331a0

10.1002/j.1460-2075.1992.tb05245.x

10.1073/pnas.93.13.6476

10.1073/pnas.94.25.13677

10.1016/S0959-8049(97)00059-2

10.1097/00001622-199601000-00012

10.1073/pnas.95.1.90

10.1136/jcp.50.2.106

10.1016/S0959-437X(99)80055-0

10.1126/science.7544491

10.1126/science.277.5328.955

10.1093/hmg/6.12.2011

10.1016/S0092-8674(00)81933-9

10.1016/S0002-9440(10)65627-1

Yashima K, 1998, Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma, Clin Cancer Res, 4, 229

10.1002/(SICI)1097-0215(19990105)80:1<1::AID-IJC1>3.0.CO;2-U

10.1016/S0022-5347(05)68162-1

10.1002/(SICI)1097-0142(19990815)86:4<559::AID-CNCR3>3.0.CO;2-4

10.1002/(SICI)1097-0215(19990315)80:6<804::AID-IJC2>3.0.CO;2-B

Wu A, 2038, Correlation of the expression of human telomerase subunits with telomerase activity in normal skin and skin tumors, Cancer, 1999, 86:

10.1053/hupa.2000.19299

10.1038/22780

10.1016/S0378-1119(99)00108-0

Ulaner G A, 1998, Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts, Cancer Res, 58, 4168

10.1093/molehr/5.9.845

10.1002/(sici)1097-0215(20000201)85:3<330::aid-ijc6>3.3.co;2-l

10.1002/(SICI)1096-9896(200001)190:1<80::AID-PATH498>3.0.CO;2-7

10.1038/sj.neo.7900112

10.1038/sj.neo.7900113

10.1016/S0165-4608(96)00329-9

10.1053/gast.1997.v112.pm9024303

10.1136/jcp.52.10.725

10.1111/j.1572-0241.2000.01855.x

10.1002/(sici)1097-0142(20000115)88:2<312::aid-cncr10>3.3.co;2-i

Kanamaru T, 1999, Clinical implications of telomerase activity in resected hepatocellular carcinoma, Int J Mol Med, 4, 267

10.1038/ng0198-65

Wada E, 1998, Genetic diagnostic test of hepatocellular carcinoma by telomerase catalytic subunit mRNA, Oncol Rep, 5, 1407

Hisatomi H, 1999, Levels of telomerase catalytic subunit mRNA as a predictor of potential malignancy, Int J Oncol, 14, 727

10.1054/bjoc.1999.1008

10.1016/S0959-8049(99)00284-1

10.1002/(sici)1097-0142(19980515)82:10<1831::aid-cncr4>3.3.co;2-h

10.1002/hep.1840220341

Young I D, 1991, Transcription of cRNA for in situ hybridization from polymerase chain reaction‐amplified DNA, Lab Invest, 64, 709

Braissant O, 1998, A simplified in situ hybridization protocol using non‐radioactively labeled probes to detect abundant and rare mRNAs on tissue sections, Biochemica, 1, 10

10.1002/1096-9896(2000)9999:9999<::AID-PATH786>3.0.CO;2-G

10.1038/sj.onc.1203733

10.1073/pnas.96.9.5147

10.1016/S1074-7613(00)80066-7

10.1016/S0009-8981(99)00188-6

10.1002/(sici)1096-9896(199911)189:3<344::aid-path430>3.0.co;2-g

10.1126/science.276.5309.60

10.1126/science.287.5456.1253

Thông tin
Thông tin xuất bản

Wiley

Tập 22 Số 1

57-69

Thông tin tác giả